- Home
- CTXR vs SCNX Comparison
CTXR vs SCNX Comparison
Compare CTXR & SCNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTXR
- SCNX
- Stock Information
- Founded
- CTXR 2007
- SCNX 2010
- Country
- CTXR United States
- SCNX United States
- Employees
- CTXR N/A
- SCNX N/A
- Industry
- CTXR Biotechnology: Pharmaceutical Preparations
- SCNX Other Pharmaceuticals
- Sector
- CTXR Health Care
- SCNX Health Care
- Exchange
- CTXR Nasdaq
- SCNX Nasdaq
- Market Cap
- CTXR 22.6M
- SCNX 21.2M
- IPO Year
- CTXR N/A
- SCNX 2020
- Fundamental
- Price
- CTXR $1.29
- SCNX N/A
- Analyst Decision
- CTXR Strong Buy
- SCNX
- Analyst Count
- CTXR 3
- SCNX 0
- Target Price
- CTXR $53.00
- SCNX N/A
- AVG Volume (30 Days)
- CTXR 414.8K
- SCNX 432.5K
- Earning Date
- CTXR 08-12-2025
- SCNX 11-05-2025
- Dividend Yield
- CTXR N/A
- SCNX N/A
- EPS Growth
- CTXR N/A
- SCNX N/A
- EPS
- CTXR N/A
- SCNX N/A
- Revenue
- CTXR N/A
- SCNX $128,202.00
- Revenue This Year
- CTXR N/A
- SCNX N/A
- Revenue Next Year
- CTXR $851.67
- SCNX N/A
- P/E Ratio
- CTXR N/A
- SCNX N/A
- Revenue Growth
- CTXR N/A
- SCNX N/A
- 52 Week Low
- CTXR $0.65
- SCNX $0.69
- 52 Week High
- CTXR $12.84
- SCNX $9.55
- Technical
- Relative Strength Index (RSI)
- CTXR 50.95
- SCNX 31.37
- Support Level
- CTXR $1.11
- SCNX $0.75
- Resistance Level
- CTXR $1.52
- SCNX $0.89
- Average True Range (ATR)
- CTXR 0.08
- SCNX 0.05
- MACD
- CTXR 0.02
- SCNX 0.02
- Stochastic Oscillator
- CTXR 39.03
- SCNX 16.53
About CTXR Citius Pharmaceuticals Inc.
Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others.
About SCNX Scienture Holdings Inc. Common Stock
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.